slide-1
slide-3
slide-2

WELCOME TO INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes

Substantial progress made

INNODIA publishes year 1 report

Summary of year 1 report


About innodia

INNODIA is an international consortium under the Innovative Medicines Initiative (IMI). 26 academic institutions and clinics, 4 industrial partners (EFPIA), 2 patient organizations and one SME have joined forces to significantly improve the understanding of type 1 Diabetes and to pave the way to novel therapeutic options to prevent and cure this disease.

group

33 partner

map
corner
x
For more information select one of the following partners

ACADEMIC paRtners

  • KU Leuven
  • ULB
  • MUG
  • UCPH
  • HH RH
  • INSERM
  • UH
  • UOULU
  • UTU
  • HKA
  • HMGU
  • TUD
  • UULM
  • UNISI
  • UD‘A
  • UPI
  • CHL
  • UiO
  • SUM
  • UL
  • UNIL
  • RUMC
  • LUMC
  • UCAM
  • KCL
  • MRC

EFPIA

  • Sanofi
  • Novo Nordisk
  • Eli Lilly
  • GSK

SME

  • Univercell-Biosolutions

Foundations

  • JDRF
  • THCT
imi eu efpia jdrf helmsley